BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31978797)

  • 21. VLA-4 is involved in the engraftment of the human pre-B acute lymphoblastic leukaemia cell line NALM-6 in SCID mice.
    Filshie R; Gottlieb D; Bradstock K
    Br J Haematol; 1998 Sep; 102(5):1292-300. PubMed ID: 9753059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shp2 regulates chlorogenic acid-induced proliferation and adipogenic differentiation of bone marrow-derived mesenchymal stem cells in adipogenesis.
    Zhou RP; Deng MT; Chen LY; Fang N; Du C; Chen LP; Zou YQ; Dai JH; Zhu ML; Wang W; Lin SJ; Liu RH; Luo J
    Mol Med Rep; 2015 Jun; 11(6):4489-95. PubMed ID: 25634525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of heme oxygenase-1 in bone marrow stromal cells promotes microenvironment-mediated imatinib resistance in chronic myeloid leukemia.
    Liu P; Ma D; Yu Z; Zhe N; Ren M; Wang P; Yu M; Huang J; Fang Q; Wang J
    Biomed Pharmacother; 2017 Jul; 91():21-30. PubMed ID: 28445830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Membrane microvesicles as mediators for melanoma-fibroblasts communication: roles of the VCAM-1/VLA-4 axis and the ERK1/2 signal pathway.
    Zhao XP; Wang M; Song Y; Song K; Yan TL; Wang L; Liu K; Shang ZJ
    Cancer Lett; 2015 May; 360(2):125-33. PubMed ID: 25661735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of beta 1 integrin intracytoplasmic domains in the regulation of VLA-4-mediated adhesion of human T cells to VCAM-1 under flow conditions.
    Rosenthal-Allieri MA; Ticchioni M; Breittmayer JP; Shimizu Y; Bernard A
    J Immunol; 2005 Jul; 175(2):1214-23. PubMed ID: 16002725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of bone marrow stromal cells and VLA-4 antibody on apoptosis of childhood leukemia cells].
    Li ZX; Jia XH; Li JC; Han L
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Nov; 12(11):897-901. PubMed ID: 21083987
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Ruan Y; Kim HN; Ogana HA; Gang EJ; Li S; Liu HC; Bhojwani D; Wayne AS; Yang M; Kim YM
    Exp Ther Med; 2022 Jan; 23(1):47. PubMed ID: 34934426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vicious cycle between myeloma cell binding to bone marrow stromal cells via VLA-4-VCAM-1 adhesion and macrophage inflammatory protein-1alpha and MIP-1beta production.
    Abe M; Hiura K; Ozaki S; Kido S; Matsumoto T
    J Bone Miner Metab; 2009; 27(1):16-23. PubMed ID: 19057841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of VCAM-1 and its associated molecule CD44 leads to increased malignant potential of breast cancer cells.
    Wang PC; Weng CC; Hou YS; Jian SF; Fang KT; Hou MF; Cheng KH
    Int J Mol Sci; 2014 Feb; 15(3):3560-79. PubMed ID: 24583847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells.
    Tang C; Luo H; Luo D; Yang H; Zhou X
    Oncol Rep; 2018 Feb; 39(2):611-618. PubMed ID: 29207183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
    Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
    J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers.
    Pillozzi S; Masselli M; De Lorenzo E; Accordi B; Cilia E; Crociani O; Amedei A; Veltroni M; D'Amico M; Basso G; Becchetti A; Campana D; Arcangeli A
    Blood; 2011 Jan; 117(3):902-14. PubMed ID: 21048156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin α-4-β-1 (VLA-4) with natalizumab can overcome this resistance.
    Mraz M; Zent CS; Church AK; Jelinek DF; Wu X; Pospisilova S; Ansell SM; Novak AJ; Kay NE; Witzig TE; Nowakowski GS
    Br J Haematol; 2011 Oct; 155(1):53-64. PubMed ID: 21749361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B-precursor acute lymphoblastic leukemia.
    Morishita N; Tsukahara H; Chayama K; Ishida T; Washio K; Miyamura T; Yamashita N; Oda M; Morishima T
    Pediatr Blood Cancer; 2012 Jul; 59(1):83-9. PubMed ID: 22183914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukemia-on-a-chip: Dissecting the chemoresistance mechanisms in B cell acute lymphoblastic leukemia bone marrow niche.
    Ma C; Witkowski MT; Harris J; Dolgalev I; Sreeram S; Qian W; Tong J; Chen X; Aifantis I; Chen W
    Sci Adv; 2020 Oct; 6(44):. PubMed ID: 33127669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
    Iwasa M; Miura Y; Fujishiro A; Fujii S; Sugino N; Yoshioka S; Yokota A; Hishita T; Hirai H; Andoh A; Ichinohe T; Maekawa T
    Int J Hematol; 2017 May; 105(5):587-597. PubMed ID: 28044259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of vascular endothelial growth factor secretion by childhood acute lymphoblastic leukemia cells via the FLT-3 signaling pathway.
    Markovic A; MacKenzie KL; Lock RB
    Mol Cancer Ther; 2012 Jan; 11(1):183-93. PubMed ID: 22084166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ectopic Tumor VCAM-1 Expression in Cancer Metastasis and Therapy Resistance.
    VanHeyst KA; Choi SH; Kingsley DT; Huang AY
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic changes in a childhood acute lymphoblastic leukemia cell line during the adaptation to vincristine.
    Guzmán-Ortiz AL; Aparicio-Ozores G; Valle-Rios R; Medina-Contreras O; Patiño-López G; Quezada H
    Bol Med Hosp Infant Mex; 2017; 74(3):181-192. PubMed ID: 29382485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.